The Influence of Uremia on Pharmacokinetics and Protein Binding of Prednisolone

Acta Medica Scandinavica

Volumn 213, Issue 5, 1983, Pages 333-337

  Bergrem, Harald ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

prednisolone; prolonged elimination; reduced protein binding; uremia

Indexed keywords

PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY FAILURE; NORMAL HUMAN; PHARMACOKINETICS; PROTEIN BINDING; UREMIA; VOLUNTEER;

ADULT; AGED; FEMALE; GLOMERULONEPHRITIS; HALF-LIFE; HUMAN; KIDNEY; KINETICS; MALE; MIDDLE AGE; POLYCYSTIC KIDNEY DISEASES; PREDNISOLONE; PROTEIN BINDING; PYELONEPHRITIS; SUPPORT, NON-U.S. GOV'T; UREMIA;

EID: 0020526461     PISSN: 00016101     EISSN: 09546820     Source Type: Journal    
DOI: 10.1111/j.0954-6820.1983.tb03747.x     Document Type: Article

References (33)

1. The binding of drugs to plasma proteins from patients with poor renal function
2. Abnormal drug binding in uremia
3. The effect of experimental uremia on the disappearance of prednisolone in uremic rats
4. A comparative study of the metabolism of hydrocortisone and prednisolone
5. Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings
6. Rejection crises in human renal transplant recipients. Control with high dose methyl‐prednisolone therapy
7. Disappearance of high dose prednisolone from plasma after renal transplantation
8. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric‐coated prednisolone
9. Absorption of prednisolone. The effect of fasting, food, and food combined with antacids
10. Bioavailability of prednisolone. A study of prednisolone pharmacokinetics including protein binding after oral and intravenous administration of different doses
11. Errors in interpretation of data from equilibrium dialysis protein binding experiments
12. Noncompartmental determination of the volume of distribution at steady state
13. Studies with tritiated digoxin in renal failure
14. Prolonged serum half‐life of cortisol in renal failure
15. Metabolism of free and conjugated 17‐hydroxicorticosteroids in subjects with uremia
16. Urinary metabolic products of prednisone and prednisolone
17. 14C prednisolone
18. 14
19. Prednisolone levels in the plasma and urine. A study of two preparations in man
20. Simultaneous measurement of prednisone, prednisolone and 6 beta‐hydroxyprednisolone in urine by high‐performance liquid chromatography coupled with a radioactive detector
21. Prednisolone clearance in renal transplantation
22. Pharmacokinetics and effects of propranolol in terminal uremic patients and in patients undergoing regular dialysis treatment
23. Water soluble steroid conjugates. II. Metabolism of prednisone‐21‐glycinate and of cortisol‐21‐sulphate in the perfused dog liver
24. Experimentelle und klinische Untersuchungen mit syntethischen wasserlöslichen Steroidkonjugaten beim Menschen
25. Dose dependent prednisolone kinetics
26. Dose dependent pharmacokinetics of prednisone and prednisolone in man
27. Correction of protein binding defect in uremic sera by charcoal treatment
28. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors
29. Alteration of plasma albumin in relation to decreased drug binding in uremia
30. Plasma and tissue protein bindings of drugs in pharmacokinetiks